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Abstract: The omega-3 polyunsaturated fatty acids (ω-3 PUFAs), eicosapentaenoic acid 
(EPA) and docosahexaenoic acid (DHA), derived mainly from fish oil, play important roles 
in brain development and neuroplasticity. Here, we reported that application of ω-3 PUFAs 
significantly  protected  mouse  neural  progenitor  cells  (NPCs)  against  H2O2-induced 
oxidative  injury.  We  also  isolated  NPCs  from  transgenic  mice  expressing  the 
Caenorhabditis elegans fat-1 gene. The fat-1 gene, which is absent in mammals, can add a 
double bond into an unsaturated fatty acid hydrocarbon chain and convert ω-6 to ω-3 fatty 
acids. Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)  staining 
showed that a marked decrease in apoptotic cells was found in fat-1 NPCs after oxidative 
injury with H2O2 as compared with wild-type NPCs. Quantitative RT-PCR and Western blot 
analysis demonstrated a much higher expression of nuclear factor erythroid 2-related factor 2 
(Nrf2), a master transcriptional factor for antioxidant genes, in fat-1 NPCs. The results of the 
study provide evidence that ω-3 PUFAs resist oxidative injury to NPCs. 
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1. Introduction 
Oxidative stress-induced neuronal apoptosis plays a critical role in the pathogenesis of stroke and 
neurodegenerative diseases [1,2]. Oxidants, such as hydrogen peroxide and free radicals, produce cell 
damage  by  inducing  production  of  reactive  oxygen  species  (ROS)  and  activate  an  inflammatory 
response [3]. Several studies confirmed the transcription factor nuclear factor erythroid 2-related factor 2 
(Nrf2)  represents  an  important  cellular  protective  mechanism  against  oxidative  stress  over  the 
Nrf2-ARE  pathway  [4,5].  Activation  of  Nrf2  signaling  induces  the  transcriptional  regulation  of 
ARE-dependent expression of various antioxidant and phase II detoxification enzymes, which include 
hemeoxygenase-1 (HO-1), NAD(P)H quinine oxidoreductase 1 (NQO-1), glutamate-cysteine ligase 
modiﬁer subunit (GCLM), and glutamate-cysteine ligase catalytic subunit (GCLC) [6]. 
The  long-chain  omega-3  polyunsaturated  fatty  acids  (ω-3  PUFAs)  from  fish  oil,  for  example, 
Docosahexaenoic acid (DHA), are highly enriched in the brain and play a key role in brain development 
and  repair  under  many  conditions  [7,8].  Dietary  DHA  has  been  suggested  to  improve  neuronal 
development [9], restore and enhance cognitive functions [10–12], and protect against beta-amyloid 
production, accumulation, and potential downstream toxicity in an aged Alzheimer mouse model [13]. 
DHA have also been shown to exert a beneficial effect on ROS related cellular damage [14]. These 
studies indicate that omega-3, such as DHA, can increase neural resistance to various types of insults. 
Mammals are unable to synthesize ω-3 PUFAs de novo and must rely on a dietary source of these 
essential fatty acids. The C. elegans fat-1 gene encodes an n-3 fatty acid desaturase that converts ω-6 to 
ω-3 PUFA, which could significantly reduce the omega-6/omega-3 fatty acid ratio [15]. The fat-1 
transgenic mice are rich in endogenous ω-3 PUFAs, specifically in the brain, with a reduction in ω-6 
fatty acids, which provides an optimal model to evaluate the actions of ω-3 PUFAs [16,17]. 
In the present study, we investigated whether ω-3 PUFAs could protect neural progenitor cells 
(NPCs) against oxidative injury. NPCs are multipotent with a broad self-renewing potential and with the 
capacity to generate neurons, astrocytes and oligodendrocytes. Their inherent biological properties of 
NPCs  provide  multiple  potentials  to  treat  various  neurological  dysfunctions.  Our  results  provide 
evidence that both exogenous and endogenous ω-3 PUFAs can resist oxidative injury to NPCs. 
2. Results 
2.1. In Vitro Characterization of NPCs
WT and NPCs
fat-1 
Neural  progenitor  cells  (NPCs)  are  self-renewing,  multipotent  cells  that  could  be  effectively 
differentiated into neurons, astrocytes, and oligodendrocytes [18]. With bFGF-supplemented culture 
medium, both NPCs
WT and NPCs
fat-1 cells showed bipolar or multipolar morphology with small cell 
bodies. Nestin is an intermediate filament protein and widely used as a specific marker for NPCs. 
Immunostaining  showed  that  more  than  95%  cells  in  both  NPCs
WT  and  NPCs
fat-1  culture  were 
nestin-positive, confirming that the majority of NPCs
WT and NPCs
fat-1 were immature (Figure 1A). PCR 
analysis demonstrated the high expression of fat-1 in NPCs
fat-1 (lanes 3 and 4) while no expression in 
NPCs
WT (lanes 1 and 2) (Figure 1B). To study differentiation potential of NPCs
WT and NPCs
fat-1 in vitro, 
bFGF was replaced with 1% FBS in the cell culture medium and NPCs began to differentiate. At the 5th 
day,  cultures  with  this  differentiating  medium,  both  NPCs
WT  and  NPCs
fat-1  were  successfully Mar. Drugs 2014, 12  2343 
 
differentiated into Tuj1-positive neurons, GFAP-positive astrocytes and Rip-positive oligodendrocytes 
with  similar  differentiation  capacities  (NPCs
WT:  14.7%  neurons,  61.3%  astrocytes,  and  11.5% 
oligodendrocytes;  NPCs
fat-1:  15.4%  neurons,  65.6%  astrocytes,  and  12.1%  oligodendrocytes)  
(Figure 1C,D). 
Figure 1. Characterization on NPCs
WT and NPCs
fat-1. (A) The purity of neural progenitor 
cells (NPCs) was identified by Nestin staining and nuclei were counter-stained with DAPI. 
More than 95% of NPCs
WT or NPCs
fat-1 were nestin-positive cells; (B) Gel electrophoresis of 
PCR products using primers for fat-1 gene. Wild-type controls (lanes 1 and 2) and positive 
fat-1 specimens (lanes 3 and 4); (C) Both NPCs
WT and NPCs
fat-1 were shown to successfully 
differentiate  into  Tuj1-positive  neurons,  GFAP-positive  astrocytes,  and  Rip-positive 
oligodendrocytes; (D) The bar graph showing the percentage of neural cells differentiated 
from NPCs at the 5th day in the differentiating medium. Scale bar: 250 μm in (A) and  
100 μm in (C). 
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2.2. DHA Protected NPCs against H2O2-Mediated Apoptosis 
To evaluate the effect of H2O2 on cell viability, we first incubated NPCs with 200 μM H2O2 and 
investigated cell viability at different time points. Cell viability was measured using the WST-8 assay. A 
200 μM concentration of H2O2 in culture was used to establish the oxidative injury model according to a 
previous study reporting that cultured NPCs exposed to H2O2 at this concentration was sufficiently 
induced to undergo apoptosis [19]. As shown in Figure 2A, cell viability was significantly reduced in a 
time-dependent manner. Incubation of 200 μM H2O2 for 6 h caused an approximate 50% cell loss, which 
was considered to be an optimal oxidative injury model for investigating drug effects. 
Figure 2. DHA pretreatment reduced oxidative stress on cultured NPCs. (A) WST-8 assays 
revealed  that  incubation  of  200  μM  H2O2  has  caused  a  significant  cytotoxicity  in  a 
time-dependent  manner.  (B)  DHA  prevented  H2O2-induced  cell  death  in  a 
concentration-dependent manner. Cell viability was presented as a percentage of control, 
and each value represents the mean ±  SD of three independent experiments; * p < 0.05 and 
** p < 0.001 versus control. 
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We then investigated the neuroprotective effects of exogenous DHA on H2O2-mediated apoptosis. 
NPCs
WT at the confluence of 80% was pretreated with DHA (0, 0.1, 1, 10, and 50 μM) for 2 h and then 
suffered an oxidative injury induced by incubation of 200 μM H2O2 for 6 h. WST-8 assay revealed that 
the cell viability increased in a concentration-dependent manner: The pretreatment of 1 μM DHA 
increased the cell viability by 22.1% as compared to vehicle control (p < 0.05, Figure 2B), while the 
pretreatment of 10 μM and 50 μM increased the cell viability by 35.6% and 36.2%, respectively, as 
compared to the vehicle control (p < 0.001, Figure 2B). 
2.3. NPCs
fat-1 Prevented H2O2-Mediated Apoptosis 
We further investigated anti-oxidative effects of endogenous ω-3 PUFAs in NPCs. NPCs
fat-1 were 
isolated from fat-1 mice, which are rich in endogenous ω-3 PUFAs, specifically in the brain [16,17]. 
WST-8 assay showed that NPCs
fat-1 exhibited a potent anti-oxidative effect similar to that found in the 
DHA-treated NPCs
WT group when exposed to H2O2 for 6 h. The cell viability of these two groups was 
significantly increased as compared to the vehicle control (Figure 3A). Terminal deoxynucleotidyl 
transferase-mediated UTP end-labeling (TUNEL) staining was also performed to detect H2O2-mediated 
apoptosis.  Only  a  very  small  proportion  of  intrinsic  apoptosis  were  detected  in  cultured  NPCs
WT  
(Figure 3B,F). Incubation with 200 μM H2O2 for 6 h induced approximately 40% NPCs
WT to undergo 
apoptosis (Figure 3C,F), while pretreatment of NPCs
WT with 10 μM DHA significantly attenuated 
H2O2-mediated apoptosis to less than 30% (Figure 3D,F). NPCs
fat-1 exhibited potent anti-oxidative 
properties, as shown by a significant decrease in apoptosis compared to NPCs
WT when exposed to H2O2 
for 6 h (Figure 3E,F). These findings indicated that both exogenous and endogenous ω-3 PUFAs could 
protect NPCs against H2O2-mediated oxidative injury. Mar. Drugs 2014, 12  2346 
 
Figure 3. NPCs
fat-1 attenuated H2O2-mediated apoptosis. (A) The cell viability of NPCs was 
assessed after exposure to H2O2 for 6 h by WST-8 analysis. Each value represents the  
mean ±  SD of three independent experiments (n = 3, ** p < 0.01 versus other groups);  
(B–E) Representative photomicrographs of TUNEL assay; (F) Quantitative analysis was 
carried out by measuring TUNEL-positive cells in each group. Figures were selected as 
representative data from three independent experiments. Cell apoptosis was significantly 
reduced in DHA-pretreated NPCs
WT and NPCs
fat-1. Each value represents the mean ±  SD of 
three independent experiments (n = 3, ** p < 0.01 versus other groups). Scale bar: 75 μm. 
 
2.4. Expression Analyses of Nrf2-ARE Pathway Genes 
To study the anti-oxidative mechanisms of ω-3 PUFAs against H2O2-induced apoptosis in NPCs, we 
first investigated whether Nrf2, the principal transcription factor that regulates the basal and inducible 
expression of a battery of antioxidant genes, was up-regulated after pretreatment with DHA and in 
NPCs
fat-1. Real-time RT-PCR assays showed that both DHA pretreatment and NPCs
fat-1 induced a nearly 
2.5-fold  increase  in  the  transcript  level  of  Nrf2  when  compared  with  the  controls  (Figure  4). 
Furthermore,  significant  increases  in  the  expression  level  of  the  downstream  gene  and  phase  II 
detoxification  gene  transcripts  (HO-1,  NQO-1,  GCLC,  GCLM)  were  found  in  NPCs
fat-1  and 
DHA-pretreated NPCs
WT (Figure 4). Mar. Drugs 2014, 12  2347 
 
Figure 4. Expression analyses of Nrf2-ARE pathway genes in DHA-pretreated NPCs
WT and 
NPCs
fat-1. Real-time RT-PCR assays showed that both DHA pretreatment and NPCs
fat-1 
induced significant increases in the transcript level of Nrf2 and its downstream gene and 
phase II detoxification gene transcripts HO-1, NQO-1, GCLC, GCLM when compared with 
the controls. Data are shown as mean ±  SD (n = 3); * p < 0.05 versus control; ** p < 0.01 
versus control. 
 
2.5. Expression Profiles of Nuclear and Cytosolic Nrf2 by Western Blot Analysis 
Real-time  RT-PCR  assays  demonstrated  that  both  DHA  pretreatment  and  NPCs
fat-1  induced 
significant increases in the transcript level of Nrf2. As nuclear translocation of protein Nrf-2 is very 
critical in inducing gene expression of anti-oxidant genes, we then investigated the expression profiles of 
cytosolic and nuclear fraction Nrf2 by Western blot analysis. Consistent with real-time RT-PCR results, 
Western blot analysis demonstrated that both DHA pretreatment and NPCs
fat-1 significantly increased 
the protein expression of nuclear Nrf2 when compared with the controls (Figure 5A,C). However, the 
expression of cytosolic Nrf2 in DHA pretreatment and NPCs
fat-1 was significantly decreased when 
compared with the control (Figure 5B,D). These results demonstrated an obvious translocation of Nrf2 
from the cytoplasm to the nucleus in DHA pretreatment and NPCs
fat-1. Mar. Drugs 2014, 12  2348 
 
Figure 5. DHA pretreatment and NPCs
fat-1 induced a significant increase in nuclear Nrf2 
expression and a significant decrease in cytosolic Nrf2 expression. DHA-pretreated NPCs
WT 
and NPCs
fat-1 were treated with 200 μM H2O2 for the indicated time points. Cells were lysed 
and  fractionated  to  isolate  nuclear  and  cytosolic  fractions  as  indicated.  Fractions  were 
confirmed using Western blot with histone H3 for nuclear fractions (A) and β-actin as a 
marker for cytosolic fractions (B); Densitometry analysis showed that DHA pretreatment 
and NPCs
fat-1 induced a significant increase in nuclear Nrf2 expression (C) and a significant 
decrease in cytosolic Nrf2 expression (D). Data are shown as mean ±  SD (n = 3); * p < 0.05 
versus control; ** p < 0.01 versus control. 
 
3. Discussion 
Neurodegenerative  diseases  are  characterized  by  the  progressive  loss  of  neurons  and  usually 
influence  the  cognitive  function,  movement  control  or  muscle  strength  [1,2].  Neurodegenerative 
diseases are commonly late-onset disorders, including Alzheimer’s disease (AD), Parkinson’s disease 
(PD), Huntington’s disease (HD), and Amyotrophic lateral sclerosis (ALS). Oxidative stress has a 
significant role in the pathogenesis and/or progression of several neurodegenerative diseases and aging 
diseases,  which  are  closely  associated  with  disease-specific  proteins  aggregation,  inflammation, 
mitochondrial dysfunction, and neurotoxicity [1,2,18]. Effective antioxidants have promising potential 
for therapeutic application. A prospective strategy in disease control has been focused on development 
of antioxidants as preventive and therapeutic medicine. 
NPCs are largely undifferentiated cells originating in the central nervous system. They have the 
potential  to  give  rise  to  offspring  cells  and  efficiently  differentiate  into  neurons,  astrocytes  and 
oligodendrocytes [19,20]. The inherent biological properties of NPCs may provide multiple strategies to 
treat CNS dysfunction and enable them to be an optimal model to screen antioxidants, which have 
therapeutic potentials for the treatment of neurological diseases. Mar. Drugs 2014, 12  2349 
 
DHA is an n-3 long chain PUFA, highly enriched in the central nervous system, and is critical for 
brain development and function. DHA is reported to play a neuroprotective role against oxidative stress 
in astrocytes [14], oligodendroglia cells [21], retinal ganglion cells [22], and human lymphocytes [23]. 
The animal with DHA diet or transgenic fat-1 mice rich in endogenous n-3 PUFA showed a better 
behavior performance [11–13,24]. H2O2 is a common oxidant to cause oxidative damage to cells and 
widely used in establishment of oxidative injury models [25]. Our present study reported that both 
exogenous and endogenous ω-3 PUFAs significantly protected NPCs against H2O2-induced oxidative 
injury,  suggesting  that  ω-3  PUFAs  might  be  an  effective  supplement  for  the  prevention  of 
neurodegenerative  diseases  which  are  associated with  oxidative stress.  DHA has  been  reported  to 
scavenge the intracellular radical productions induced by hydrogen peroxide (H2O2), superoxide anion 
(O2
•−), and hydroxyl radical (•OH) [22]. Many previous studies reported that DHA treatment could 
significantly reduce ROS production, which is a possible mechanism underlying DHA’s protective 
effects  [14].  However,  no  significant  differences  in  intracellular  ROS  levels  were  found  between 
treatments in our study using 2′,7′-dichlorofluorescin diacetate (DCFH-DA) to measure intracellular 
ROS levels. A previous study reported that DHA at some certain concentrations showed no effects on 
the fluorescence change by use of ROS probe [26]. It could be a reason why we were unable to detect the 
differences in intracellular ROS levels between the DHA treatment and control group. Another possible 
reason may be the cell type used in our study. Our study investigated whether DHA could protect NPCs 
against oxidative injury. NPCs are capable of self-renewal and they grow and proliferate rapidly in the 
culture, which may make it difficult to accumulate ROS to sufficient levels for measurement inside cells. 
To detect ROS changes in NPCs may require more sensitive methods or probes. Regarding protective 
effects of DHA on attenuating oxidative stress/damage induced by H2O2, our study suggests that DHA 
exert its antioxidative effects possibly via initiating a translocation of Nrf2 from the cytoplasm to the 
nucleus  and  subsequently  stimulating  the  expression  of  a  battery  of  antioxidant  and  phase  II 
detoxification molecules as a response to oxidative injury. 
The nuclear factor erythroid 2-related factor 2 (Nrf2) is an emerging regulator of cellular resistance to 
oxidants  [4–6].  Nrf2  is  localized  mainly  in  the  cytoplasm  bound  to  its  specific  repressor  Keap1. 
Oxidative stress will cause the liberation of Nrf2 and allow it to translocate into the nucleus. Nrf2 will 
induce transcriptional upregulation of numerous antioxidant and phase II detoxification genes to provide 
efficient cytoprotection [27]. The activated Nrf2 has shown protective effects in animal models of many 
neurodegenerative disorders [28–30]. In the present investigation, we demonstrated that both exogenous 
and endogenous DHA enhanced Nrf2 translocation from the cytoplasm to the nucleus of cultured NPCs 
when exposed to the oxidative stress and subsequently stimulated the mRNA levels of Nrf2, GCLC, 
GCLM, NQO-1, and HO-1. These results confirm previous findings that treatment of DHA can induce 
antioxidant and detoxifying genes [31,32]. 
Although our study demonstrated a similar antioxidative effect between exogenous and endogenous 
DHA on cultured NPCs, a difference in mechanisms underlying protective effects of exogenous and 
endogenous  DHA  may  exist.  The  fat-1  gene,  which  is  absent  in  mammals,  encodes  omeg-3 
polyunsaturated fatty acids (ω-3 PUFAs) that convert ω-6 to ω-3 PUFAs, leading to an elevated amount 
of ω-3 PUFAs such as DHA and higher ω-3 PUFAs/ω-6 PUFAs ratio in cells and tissues from fat-1 
mice. PUFAs are essential components of membrane phospholipids and have a specific influence on 
membrane properties. Membranes enriched in ω-3 PUFAs show increased membrane fluidity [33] and Mar. Drugs 2014, 12  2350 
 
can directly or indirectly affect the function of a number of membrane proteins such as receptors since 
receptors and their affinity to their respective hormones/growth factors/proteins depend on the fluidity of 
the cell membrane [34,35]. The increased membrane fluidity can be involved in antioxidative effects of 
endogenous DHA in addition to its direct action on initiating Nrf2 translocation from the cytoplasm to 
the nucleus, while exogenous DHA is considered to exert its antioxidative effects possibly via a direct 
action  on  initiating  a  translocation  of  Nrf2  from  the  cytoplasm  to  the  nucleus  and  subsequently 
stimulating the expression of a battery of antioxidant and phase II detoxification molecules as a response 
to oxidative injury. 
4. Experimental Section 
4.1. Animals 
We obtained fat-1 breeders on a C57BL/6 background from Dr. Jing X. Kang (Harvard Medical 
School, Boston, MA, USA) and arose in the Laboratory Animal Center, University of Macau (Macau, 
China). Mice were housed in a temperature-controlled, 12:12 light/dark room and were allowed free 
access to water and food. The F1 progeny were obtained by mating C57BL/6 ×  C3H fat-1 breeders with 
C57BL/6 WT mice. Generations of heterozygous fat-1 mice were then mated with WT littermates to 
obtain WT and heterozygous fat-1 mice. All animals were treated in accordance with prevailing laws on 
animal  experiments  that  were  approved  by  the  ethical  committee  of  the  University  of  Macau  
(Macau, China). 
4.2. Genomic DNA Extractions and PCR Amplification 
The fat-1 C57BL6 mice (fat-1) and fat-1 negative C57BL6 mice (WT) were identified by genotyping 
using PCR. Genomic DNA was prepared from 1 to 2 mm sections of tail tip using DNA Isolation Kit for 
Cells  and  Tissues  (Roche,  Mannheim,  Germany).  The  DNA  was  used  running  polymerase  chain 
reactions (PCR) using oligonucleotide primers that are specific for the transgene. Primer pair sets for the 
fat-1 gene were constructed from Invitrogen (Carlsbad, CA, USA) and were as follows: Fat-1 forward: 
5′-TGTTCATGCCTTCTT-CTTTTTCC-3′;  reverse:  5′-GCGACCATACCTCAAACTTGGA-3′.  PCR 
was carried out using rTaq (Takara, Otsu, Japa) with the following conditions: 95 ° C 60 s (1 cycle);  
95 ° C 20 s, 58 ° C 30 s, 72 ° C 40 s (34 cycles). Amplified fragments were separated by 1.5% agarose  
gel electrophoresis. 
4.3. Cell Isolation and Culture 
Under sterile conditions, cerebral cortex from E13.5 fat-1 mice and WT littermates were dissected out 
and prepared for NPCs culture following procedures described previously with minor modifications [25]. 
Briefly, the cortex was separated from surrounding tissues. After peeling off the meninges, the cortex 
was  transferred  into  a  15  mL  centrifuge  tube  containing  culture  medium  (described  below)  and 
dissociated to a single-cell suspension by gentle mechanical trituration through a fire polished Pasteur 
pipette. The dissociated cells were filtered through a cell strainer (BD Falcon, Franklin Lakes, NJ, USA) 
and then cultured in T25 flask in suspension. The culture medium consisted of DMEM-F12, BSA  
(1 mg/mL), B27 (20 IU/mL), N2 (10 IU/mL), EGF (20 ng/mL), and bFGF (20 ng/mL). Cells were Mar. Drugs 2014, 12  2351 
 
maintained in an incubator with a humidified atmosphere containing 5% CO2 at 37 ° C. NPCs isolated 
from fat-1 mice and their WT littermates were confirmed by genomic DNA analyses and designated as 
NPCs
fat-1 and NPCs
WT respectively. The medium was changed every two days. After five to six days, 
cells grew in neurospheres with the diameter of approximately 150 μm. Cells in the neurospheres were 
passaged at the ratio of 1:6 after initial plating. These subcultured cells were designated as “first 
passage”  (P1).  The  third  passage  (P3)  cells  were  used  for  all  the  following  experiments.  For 
differentiation studies, growth factors were removed from the culture medium and 1% fetal bovine 
serum (FBS, Gibco, Life Technologies Inc., Grand Island, NY, USA) was added. The cultures were 
allowed to differentiate for up to five days. 
4.4. Exposure to H2O2 and Pretreatment with DHA 
Dilutions of H2O2 (Sigma-Aldrich, St. Louis., MO, USA) were made fresh from a 30% stock solution 
into cell culture medium to the different terminal concentrations. The NPCs
WT were seeded at a density 
of 1 ×  10
4 cells per well into 96-well plates, then incubated in a humidified atmosphere of 95% air and 
5% CO2 at 37 ° C. A 200 μM H2O2 concentration in NPCs was determined to be optimal for this study 
(data not shown). 
DHA (Sigma-Aldrich, St. Louis., MO, USA) was dissolved in 100% ethanol and kept at −20 ° C in the 
dark as described in a previous study [24]. Immediately before use, the DHA stock solution was diluted 
in the bath solution and adjusted to the final concentrations needed. To examine the protective effects of 
DHA on H2O2-mediated apoptosis, NPCs
WT at a confluence of around 75% was pretreated with DHA  
(0, 0.1, 1, 10, and 50 μM) for 2 h and followed by oxidative injury induced by H2O2 treatment. NPCs
fat-1 
were exposed to H2O2 directly to investigate the protective effects of endogenous ω-3 PUFAs against 
oxidative injury. These cultures were then proceeded to cell viability analysis and TUNEL staining. 
4.5. Analysis of Cell Viability and TUNEL 
Cell viability was assessed using the WST-8 dye (Beyotime Inst Biotech, Haimen, China) according 
to the manufacturer’s instructions. After 10 μL WST-8 dye was add to each well, cells were incubated at  
37 ° C for 2 h and the absorbance was finally determined at 450 nm using a microplate reader (Molecular 
Devices, Sunnyvale, CA, USA). The results were expressed as relative cell viability (%). The apoptotic 
cell death of NPCs was estimated using TUNEL staining (Roche Applied Science, Indianapolis, IN, 
USA) according to the manufacturer's protocol. Cell cultures were counterstained with DAPI (5 μg/mL), 
which stained the nuclei of all cells. 
4.6. Real-Time RT-PCR 
Total RNA was extracted from NPCs
WT, NPCs
fat-1 and pretreated NPCs
WT with 10 μM DHA after 
exposed to 200 μM H2O2 for 6 h using TRIzol reagent (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturer’s  instructions.  cDNAs  were  amplified  and  quantified  in  ABI  Prism  7500  Sequence 
Detection System (Applied Biosystems, Foster City, CA, USA) using dye SYBR Green I (Takara, Otsu, 
Japan). The fold change in the levels of Nrf2, HO-1, GCLC, GCLM, and NQO-1 between the NPCs
WT 
and NPCs
fat-1, normalized by the level of β-actin, was determined using the following equation: Fold Mar. Drugs 2014, 12  2352 
 
change = 2
−∆(∆Ct), where ∆Ct = Ct(target) − Ct(β-actin) and ∆(∆Ct) = ∆Ct(treated) − ∆Ct(untreated). The 
primer sequences are listed in Table 1. 
Table 1. Primers for real-time PCR assay. 
Gene  Primer (5′-3′) 
Nrf2  F: TTCTTTCAGCAGCATCCTCTCCAC 
  R: ACAGCCTTCAATAGTCCCGTCCAG 
NQO1  F: GCGAGAAGAGCCCTGATTGTACTG 
  R: TCTCAAACCAGCCTTTCAGAATGG 
HO-1  F: CAAGCCGAGAATGCTGAGTTCATG 
  R: GCAAGGGATGATTTCCTGCCAG 
GCLM  F: GCCACCAGATTTGACTGCCTTTG 
  R: TGCTCTTCACGATGACCGAGTACC 
GCLC  F: ACATCTACCACGCAGTCAAGGACC 
  R: CTCAAGAACATCGCCTCCATTCAG 
β-actin  F: TCGTGCGTGACATTAAGGAGAAG 
  R: GTTGAAGGTAGTTTCGTGGATGC 
4.7. Immunofluorescence 
Immunocytochemistry was performed to characterize NPCs
WT and NPCs
fat-1. Briefly, cells were 
fixed  with  4%  paraformaldehyde,  blocked  with  5%  goat  serum,  and  then  incubated  with  primary 
antibodies overnight at 4 ° C, including rabbit anti-nestin (1:1000, Millipore, Billerica, MA, USA), 
mouse anti-Rip (1:50, kindly gift from Dr. XM Xu, University of Louisville, Louisville, KY, USA), 
rabbit  anti-GFAP  (1:1000,  Sigma-Aldrich,  St.  Louis.,  MO,  USA),  mouse  anti-Tuj1  (1:1000, 
Sigma-Aldrich, St. Louis., MO, USA). The cells were then rinsed three times with PBS and incubated 
for 30 min with species-specific secondary antibody conjugated to the fluorescent labels Alexa 568 or 
488 (1:400, Invitrogen, Carlsbad, CA, USA). Cell cultures were counterstained with DAPI (5 μg/mL) to 
stained the nuclei of all cells. Finally, the cells were visualized under a fluorescent laser microscope 
(IX73, Olympus Corp., Tokyo, Japan). 
4.8. Western Blotting Analysis 
Cells were washed twice with ice-cold PBS and lysed using a Nuclear and Cytoplasmic Protein 
Extraction Kit (Beyotime, Haimen, China) according to the protocol described by the manufacturer. The 
protein concentrations were determined using Bradford method. The protein extracts were separated in 
sodium dodecylsulfate polyacrylamide gel electrophoresis (SDS-PAGE) gel and then transferred to a 
poly-vinylidene difluoride (PVDF) membrane. They were then incubated overnight at 4 ° C with primary 
monoclonal antibodies against Nrf2 (1:1000; R & D Systems, Minneapolis, MN, USA). Histone H3 
(1:1000;  Cell  Signaling  Technology,  Beverly,  MA,  USA)  and  β-actin  (1:1000;  Cell  Signaling 
Technology, Beverly, MA, USA) used as controls were detected in the nuclear fraction and cytosolic 
fraction, respectively. The blots were washed thoroughly in TBST buffer and incubated for 1 h with 
appropriate HRP-linked secondary antibodies (1:1000; Cell Signaling Technology, Beverly, MA, USA). 
Immunoreactive proteins were visualized with the ECL Western blotting detection reagent (Amersham Mar. Drugs 2014, 12  2353 
 
Biosciences, GE Healthcare, Piscataway, NJ,  USA).  Relative band intensities were determined by 
Quality-one 1-D analysis software (Bio-Rad, Hercules, CA, USA). 
4.9. Statistical Analysis 
The results were expressed as the mean ±  S.D. of triplicate measurements representative of three 
independent experiments. The one-way analysis of variance and Tukey test were used for the multiple 
comparisons. Statistical significance was defined as P < 0.05. 
5. Conclusions 
Both exogenous and endogenous DHA showed protective effects on NPCs against oxidative injury 
possibly  via  Nrf-ARE  pathway,  suggesting  that  DHA  might  be  an  effective  supplement  for  the 
prevention of neurodegenerative diseases which are associated with oxidative stress. 
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